0.1-0.3mm Spicule Skincare: Indie Founder Spec Sheet (2026)
Spicules are microscopic silica needles extracted from freshwater sponges (INCI: Hydrolyzed Sponge) that physically embed into the stratum corneum and create micro-channels for active ingredient delivery. The 0.1 to 0.3mm particle band sits in the cosmetic-legal zone under FDA guidance, meaning your product ships as a cosmetic, not a Class II medical device. Korean ODMs quote spicule serums at $2.80 to $5.50 per unit at 3,000 MOQ, but the formulation demands suspension stability testing most founders skip. This spec sheet covers particle grading, ODM quoting language, FDA boundary navigation, stability protocols, and per-unit economics at indie MOQ tiers.
• The 0.1 to 0.3mm spicule band delivers visible skin-texture results without crossing the FDA's 0.3mm microneedling device threshold.
• Freshwater sponge spicules (Spongilla) are biogenic silica, not synthetic. Your ODM quote must specify particle size distribution, not just average length.
• Suspension settling is the number-one formulation failure. Airless pumps or single-dose ampoules solve the packaging side, but viscosity engineering solves the formula side.
• The global spicule serum market hit $63 million in 2025 and is projected to reach $169 million by 2035, making this a category with real growth runway.
• Korean ODMs like Neo Mirae and UNIZ Lab offer end-to-end spicule OEM/ODM with KFDA certification included in the contract.
What Spicules Actually Are and Why Founders Keep Getting the Science Wrong
Spicules are needle-shaped skeletal structures extracted from freshwater sponges, primarily the species Spongilla lacustris. They are composed of biogenic silica (SiO₂) and measure between 50 and 400 micrometers depending on species and processing. When applied to skin, these microscopic needles physically embed into the stratum corneum and create micro-channels that dramatically improve the penetration of active ingredients like peptides, hyaluronic acid, and growth factors.
The confusion starts when founders treat spicules as just another exfoliant. They are not. A sugar scrub dissolves. A chemical peel loosens bonds between dead cells. A spicule physically lodges into the skin and stays there for 24 to 72 hours, creating a sustained delivery pathway. This is why Korean dermatologists started calling them "liquid microneedling" around 2023, and why the ingredient went from niche K-beauty curiosity to a $63 million global market by 2025.
The INCI name is Hydrolyzed Sponge. If your ODM quotes you "sponge extract" or "marine silica" without specifying particle morphology, you are not getting spicules. You are getting ground-up sponge powder that will do nothing for transdermal delivery.
Why the 0.1 to 0.3mm Band Is the Only One That Matters
The particle size you specify on your ODM quote determines two things simultaneously: whether your product works, and whether it ships as a cosmetic or gets flagged as a medical device.
Spicules shorter than 0.1mm (100 micrometers) lack the mechanical rigidity to penetrate the stratum corneum effectively. They sit on the surface, create mild tingling, and wash off. The consumer feels something happening but gets minimal active delivery. Products in this range produce poor repeat-purchase rates because the visible results are weak.
Spicules longer than 0.3mm (300 micrometers) cross into territory the FDA considers microneedling. The FDA treats devices with needle penetration at roughly 0.3mm or deeper as Class II medical devices requiring 510(k) clearance. Your cosmetic product becomes an unapproved medical device overnight.
The 0.1 to 0.3mm band is the sweet spot: deep enough to embed and deliver actives, short enough to remain a cosmetic under current FDA guidance. Every particle size specification on your ODM quote should reference this range explicitly, with a tolerance band no wider than plus or minus 15%.
| Size Band | Penetration Depth | Regulatory Status | Founder Verdict |
|---|---|---|---|
| Under 0.1mm | Surface only | Cosmetic | Weak results, poor retention |
| 0.1 to 0.3mm | Stratum corneum | Cosmetic | Optimal: efficacy + legal safety |
| 0.3 to 0.5mm | Upper dermis | Class II device risk | Requires 510(k), not viable for indie |
| Over 0.5mm | Mid-dermis | Medical device | Professional-only, not OTC cosmetic |
How to Write the Spicule Spec on a Korean ODM Quote
A Korean ODM quote for a spicule serum that says "contains spicule" is useless. The spec sheet needs six fields locked before you sign anything.
1. Particle size distribution, not average. Specify D10, D50, and D90 values. A D50 of 150 micrometers with a D90 under 280 micrometers keeps you safely inside the cosmetic band. If the ODM only quotes an average, push back. An average of 200 micrometers could mean 30% of particles exceed 300 micrometers, which creates regulatory exposure.
2. Spicule concentration by weight. Consumer products typically run 0.5% to 2.0% spicule by weight. Professional-grade products go up to 5%. Higher is not better for a retail launch. A 1% concentration in a well-formulated vehicle outperforms a 3% concentration in a poorly stabilized base.
3. Source species and origin. Spongilla lacustris (freshwater) is the standard. Some ODMs substitute marine sponge species with different silica morphology. The INCI stays "Hydrolyzed Sponge" either way, but the needle geometry and skin penetration behavior differ. Confirm the species in writing.
4. Vehicle type. Aqueous suspension, anhydrous gel, or single-dose lyophilized powder plus activator. Each has different stability profiles and cost structures. Aqueous is cheapest but hardest to stabilize. Lyophilized is most stable but adds $0.80 to $1.50 per unit in packaging.
5. Stability testing protocol. Request 6-month accelerated stability data at 40 degrees Celsius and 75% relative humidity. Specifically ask for sedimentation rate at T0, T30, T90, and T180. If the ODM cannot provide this, they have not solved the suspension problem.
6. KFDA notification status. Korean ODMs like Neo Mirae include KFDA certification in their OEM/ODM contracts. Confirm whether the spicule raw material itself has an existing KFDA notification, or whether your product requires a new filing. A new filing adds 4 to 8 weeks.
The Suspension Stability Problem That Kills Spicule Products
Spicules are insoluble in both water and oil phases. They are dense silica needles suspended in a liquid vehicle, and gravity wants them at the bottom of the bottle. This is the single most common formulation failure in spicule skincare, and it manifests as a product that works perfectly in month one and delivers nothing by month four because the spicules have settled into a packed cake at the bottom.
Three engineering solutions exist, and your ODM should be using at least two of them simultaneously.
Viscosity engineering. Increasing the viscosity of the continuous phase slows Stokes settling. A structured gel base using carbomer or xanthan gum at 0.3 to 0.8% creates a yield stress that holds spicules in suspension at rest. The tradeoff: higher viscosity changes the sensory profile from a lightweight serum to a gel, which may not match your brand positioning.
Packaging design. Airless pumps eliminate the air-liquid interface that accelerates oxidation and prevent the consumer from seeing sedimentation. Single-dose ampoules solve the problem entirely by removing the time variable. For a detailed cost comparison of packaging options at indie MOQ tiers, see our manufacturing cost breakdown.
Particle surface treatment. Some manufacturers coat spicules with hydrophilic polymers that improve wettability and reduce the density differential between particle and vehicle. UNIZ Lab in Korea offers coated spicule grades specifically designed for aqueous suspension stability.
Where Does the FDA Draw the Line Between Cosmetic and Device?
The FDA classifies microneedling devices with penetration at approximately 0.3mm or deeper as Class II medical devices. A spicule serum with particles in the 0.1 to 0.3mm range falls on the cosmetic side of this line, but only if you handle two things correctly.
First, your marketing claims. The moment you claim your spicule product "penetrates the dermis," "stimulates collagen production," or "replaces microneedling treatments," you have made a drug or device claim regardless of particle size. Stick to cosmetic language: "improves skin texture," "enhances the appearance of fine lines," "supports the absorption of skincare actives." The FDA regulates claims as aggressively as it regulates ingredients.
Second, your MoCRA compliance. Spicule products are cosmetics under the Modernization of Cosmetics Regulation Act (FDA overview). Your Korean ODM registers the facility (Form FDA 5066), and you file the product listing (Form FDA 5067) with full INCI and CAS numbers. Small businesses under $1 million in annual sales qualify for partial exemptions, but not for eye-area products.
The regulatory gap to watch: the FDA has not issued specific guidance on spicule cosmetics as a category. The 0.3mm threshold comes from microneedling device classification, not from a cosmetic ingredient ruling. If the FDA issues spicule-specific guidance in the future, the boundary could shift. Build your spec sheet conservatively. A D90 under 250 micrometers gives you a comfortable margin below the 300-micrometer line. For the full ODM sourcing process, see our ODM sourcing guide.
Per-Unit Cost at Indie MOQ Tiers
Spicule formulations cost more than standard serums because the raw material is expensive and the stability engineering adds complexity. Here is what the numbers look like at three MOQ tiers from Korean ODMs in 2026.
| MOQ Tier | COGS per Unit | Packaging | Suggested Retail |
|---|---|---|---|
| 1,000 units | $5.00 to $5.50 | Airless pump 30ml | $38 to $48 |
| 3,000 units | $2.80 to $3.80 | Airless pump 30ml | $32 to $42 |
| 5,000+ units | $2.20 to $3.00 | Airless pump or ampoule | $28 to $38 |
These figures include formulation, filling, primary packaging, and KFDA notification. They do not include secondary packaging (boxes, inserts), shipping to the US, customs duties, MoCRA filing, or product liability insurance. Add $1.50 to $2.80 per unit for those line items at the 3,000-unit tier.
The single-dose ampoule format adds $0.80 to $1.50 per unit over airless pump but eliminates the suspension stability risk entirely. For a first production run where you have not yet validated your formulation's shelf stability, ampoules are the safer bet even at the higher cost. A product that settles on the shelf damages your brand faster than a slightly lower margin.
Book a free 15-min K-beauty launch gut-check
partnerships@altameet.com | Manhattan, NYC × Seoul
FAQ
Can I use vegan spicules instead of freshwater sponge spicules?
Yes. Vegan spicule systems use calcium aluminum borosilicate engineered into elongated micro-rod structures that mimic natural sponge spicules. They offer more consistent particle geometry and better batch-to-batch reproducibility. The tradeoff is that clinical data on transdermal delivery with vegan spicules is thinner than the data on Spongilla-derived spicules. If "clinical proof" matters to your marketing story, natural spicules have more published studies behind them.
Do spicule products require special adverse event reporting under MoCRA?
Yes. All cosmetics sold in the US require serious adverse event reporting within 15 business days under MoCRA. Spicule products carry a slightly elevated risk of consumer complaints because the tingling and temporary redness are intended effects, not adverse reactions. Include clear usage instructions and set expectations on packaging. A well-written insert reduces complaint volume by making the sensory experience feel intentional rather than alarming.
How do I test whether my spicule serum has settled during shipping?
Run a transport simulation test (ASTM D4169) on finished goods before your first bulk shipment. This subjects packaged units to vibration, drop, and temperature cycling that mimics real freight conditions. Request this from your 3PL or a third-party testing lab. Cost: $800 to $1,500 for a standard package profile. If your product survives the test with acceptable redispersibility (meaning the consumer can shake it back to uniform suspension), your formulation and packaging combination is shipping-ready.
What is the shelf life of a typical spicule serum?
Properly formulated spicule serums in airless packaging carry 12 to 24 months of shelf life. The silica spicules themselves do not degrade, but the vehicle (preservatives, active ingredients, emulsifiers) determines the overall expiration. Your ODM should provide accelerated stability data covering at least 6 months at 40 degrees Celsius and 75% relative humidity, which predicts roughly 24 months at room temperature.
ALTA MEET helps US indie founders navigate Korean ODM contracts for specialty active ingredients, from particle size specs to MoCRA filing to first production run.
Book a free 15-minute spicule formulation gut-check with Liz
By Liz Song, K-beauty sourcing consultant | Bridging Korean ODMs and US indie brands
Reviewed for accuracy by ALTA MEET's formulation consulting team. Spicule market data from Fact.MR Spicule Serum Market Report 2025. FDA microneedling classification from FDA.gov Microneedling Devices guidance. MoCRA requirements cross-checked against FDA Cosmetics Direct guidance (Public Law 117-328). Particle size and formulation data from Grand Ingredients biogenic silica research and UNIZ Lab technical documentation.
